BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 31560953)

  • 21. Targeting Wnt/β-catenin and PI3K/Akt/mTOR pathways in T-cell acute lymphoblastic leukemia.
    Evangelisti C; Chiarini F; Cappellini A; Paganelli F; Fini M; Santi S; Martelli AM; Neri LM; Evangelisti C
    J Cell Physiol; 2020 Jun; 235(6):5413-5428. PubMed ID: 31904116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sohlh2 inhibits the apoptosis of mouse primordial follicle oocytes via C-kit/PI3K/Akt/Foxo3a signalling pathway.
    Zhang X; Zhang H; Gao Q; Ji S; Bing L; Hao J
    Reprod Biomed Online; 2015 May; 30(5):514-21. PubMed ID: 25773528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GL-V9, a newly synthetic flavonoid derivative, induces mitochondrial-mediated apoptosis and G2/M cell cycle arrest in human hepatocellular carcinoma HepG2 cells.
    Li L; Lu N; Dai Q; Wei L; Zhao Q; Li Z; He Q; Dai Y; Guo Q
    Eur J Pharmacol; 2011 Nov; 670(1):13-21. PubMed ID: 21944925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FOXO3a mediates the cytotoxic effects of cisplatin in lung cancer cells.
    Liu H; Yin J; Wang C; Gu Y; Deng M; He Z
    Anticancer Drugs; 2014 Sep; 25(8):898-907. PubMed ID: 24814195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HCRP-1 regulates EGFR-AKT-BIM-mediated anoikis resistance and serves as a prognostic marker in human colon cancer.
    Chen F; Zhang L; Wu J; Huo F; Ren X; Zheng J; Pei D
    Cell Death Dis; 2018 Dec; 9(12):1176. PubMed ID: 30518879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Forkhead Box Transcription Factor (FOXO3a) mediates the cytotoxic effect of vernodalin in vitro and inhibits the breast tumor growth in vivo.
    Ananda Sadagopan SK; Mohebali N; Looi CY; Hasanpourghadi M; Pandurangan AK; Arya A; Karimian H; Mustafa MR
    J Exp Clin Cancer Res; 2015 Dec; 34():147. PubMed ID: 26643256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FOXO3a: a novel player in thyroid carcinogenesis?
    Karger S; Weidinger C; Krause K; Sheu SY; Aigner T; Gimm O; Schmid KW; Dralle H; Fuhrer D
    Endocr Relat Cancer; 2009 Mar; 16(1):189-99. PubMed ID: 18845647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AMP-activated protein kinase couples 3-bromopyruvate-induced energy depletion to apoptosis via activation of FoxO3a and upregulation of proapoptotic Bcl-2 proteins.
    Bodur C; Karakas B; Timucin AC; Tezil T; Basaga H
    Mol Carcinog; 2016 Nov; 55(11):1584-1597. PubMed ID: 26373689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 18β-glycyrrhetinic acid induces apoptosis through modulation of Akt/FOXO3a/Bim pathway in human breast cancer MCF-7 cells.
    Sharma G; Kar S; Palit S; Das PK
    J Cell Physiol; 2012 May; 227(5):1923-31. PubMed ID: 21732363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T63, a new 4-arylidene curcumin analogue, induces cell cycle arrest and apoptosis through activation of the reactive oxygen species-FOXO3a pathway in lung cancer cells.
    Liu H; Zhou BH; Qiu X; Wang HS; Zhang F; Fang R; Wang XF; Cai SH; Du J; Bu XZ
    Free Radic Biol Med; 2012 Dec; 53(12):2204-17. PubMed ID: 23085518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PTEN-regulated AKT/FoxO3a/Bim signaling contributes to Human cell glioblastoma apoptosis by platinum-maurocalcin conjugate.
    Aroui S; Dardevet L; Najlaoui F; Kammoun M; Laajimi A; Fetoui H; De Waard M; Kenani A
    Int J Biochem Cell Biol; 2016 Aug; 77(Pt A):15-22. PubMed ID: 27210502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Copanlisib promotes growth inhibition and apoptosis by modulating the AKT/FoxO3a/PUMA axis in colorectal cancer.
    Yan J; Yang S; Tian H; Zhang Y; Zhao H
    Cell Death Dis; 2020 Nov; 11(11):943. PubMed ID: 33139695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Atypical Antipsychotic Agent, Clozapine, Protects Against Corticosterone-Induced Death of PC12 Cells by Regulating the Akt/FoxO3a Signaling Pathway.
    Zeng Z; Wang X; Bhardwaj SK; Zhou X; Little PJ; Quirion R; Srivastava LK; Zheng W
    Mol Neurobiol; 2017 Jul; 54(5):3395-3406. PubMed ID: 27173157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
    Hales EC; Taub JW; Matherly LH
    Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TG-interacting factor transcriptionally induced by AKT/FOXO3A is a negative regulator that antagonizes arsenic trioxide-induced cancer cell apoptosis.
    Liu ZM; Tseng HY; Cheng YL; Yeh BW; Wu WJ; Huang HS
    Toxicol Appl Pharmacol; 2015 May; 285(1):41-50. PubMed ID: 25791921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pazopanib, a novel multi-kinase inhibitor, shows potent antitumor activity in colon cancer through PUMA-mediated apoptosis.
    Zhang L; Wang H; Li W; Zhong J; Yu R; Huang X; Wang H; Tan Z; Wang J; Zhang Y
    Oncotarget; 2017 Jan; 8(2):3289-3303. PubMed ID: 27924057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. S-equol, a Secondary Metabolite of Natural Anticancer Isoflavone Daidzein, Inhibits Prostate Cancer Growth In Vitro and In Vivo, Though Activating the Akt/FOXO3a Pathway.
    Lu Z; Zhou R; Kong Y; Wang J; Xia W; Guo J; Liu J; Sun H; Liu K; Yang J; Mi M; Xu H
    Curr Cancer Drug Targets; 2016; 16(5):455-65. PubMed ID: 26638886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FOXO3a Activation by HDAC Class IIa Inhibition Induces Cell Cycle Arrest in Pancreatic Cancer Cells.
    Usami M; Kikuchi S; Takada K; Ono M; Sugama Y; Arihara Y; Hayasaka N; Nakamura H; Ikeda Y; Hirakawa M; Yoshida M; Miyanishi K; Kobune M; Kato J
    Pancreas; 2020 Jan; 49(1):135-142. PubMed ID: 31856089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Akt-FOXO3a signaling axis dysregulation in human oral squamous cell carcinoma and potent efficacy of FOXO3a-targeted gene therapy.
    Fang L; Wang H; Zhou L; Yu D
    Oral Oncol; 2011 Jan; 47(1):16-21. PubMed ID: 21109483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Group I metabotropic receptor neuroprotection requires Akt and its substrates that govern FOXO3a, Bim, and beta-catenin during oxidative stress.
    Chong ZZ; Li F; Maiese K
    Curr Neurovasc Res; 2006 May; 3(2):107-17. PubMed ID: 16719794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.